They probably are waiting for the protocol approval by the FDA. It is possible that the delay may have been due to certain strategic accomodation to facilitate the Breakthrough Designation. Whatever it is, they can't keep their mouth shut and not give any up-to-date information to shareholders. If so, it's an irresponsible attitude.
Who does pay you?!!! You must have ties to WS manipulating machinery, isn't it? OR are you just the one with enough money who accumulates more while scaring others to sell off so you can get those shares cheap??!! It can't be anything else!!!
Perhaps. One large seller or a hedgie playing game, correctly anticipating that the monkey traders will drag it down more so he can get back in at a lower price!! The MM may have obliged his friend, taking advantage of the overall market slide. Such games seem to be normal for the current-day WS crooks while the SEC has been in hybernation!! Thanks to politicians running our lobbies-controlled government!!
Mon..keys trading by hundred-two hundred shares kept dancing by the MM. They can't guess which way to go because half of them hop on and the other half hop off - real dancing!!
Great day to watch them rush to their computers and dance!! Real fun to watch the race for easy money!! Now.... take a vacation and meet El Chapo at the border to arrange for your 5-star vacation with girl friend and a bottle in hand!! Chapo can provide you with ecstatic substance too and get lost in the Mexican jungles.... Good bye!!!!!!!
Steve, keep it up. But, this board is not the one you need to communicate with!!
Liars and manipulators abound on this board. These insects will stay as long as they can make a dime a share a day. It is the way they make their living!!
Clearly institutional naked shorts are controlling and MM is cooperating!! Control of this stock is no longer in the hands of retail monkey traders. They just tag along. But, I have a feeling that someone is trying to grab as many shares as cheap as possible and that pretty soon the SP is going to see $5 level.
Yes, I see that comparing to the boards of such other infant-stage biotechs. Thanks to the potential success of IMET after the Mayo trial.
earfool, despite apprehension we may have, the FDA is after getting BT drugs out in the market as fast as it can. But, in case of oncological drug development, the legality issues and required long-term observational period to verify any serious side effect must be the drag. I think by going after the ODD, Janssen has taken a smart step forward OR it's possible that the FDA may have suggested that to Janssen guys. Now, with ODD, physicians are free to use when they can justify its use even before IMET is licensed. Will Medicare and insurance companies approve such a usage is another matter and that may limit the use. Good thing is that physicians are still in the highest regard ethically (not like greedy bankers! Or used-car salesmen!) and they normally do what they can to cure their patients. Accordingly, I see initially a gradual increase in adoption of IMET but it may mushroom into more widespread use faster as time passes. The issue of competition developing another alternate remains; but, any alternate also will have to go through the rigorous FDA screening before approval for commercial use. We will have to see how all that plays out..
It may go as a pivotal trial, followed by the Breakthrough Designation. My feeling, of course!
Right now it doesn't look like but, it is quite possible that that may change during the last 5 minutes since there won't be profit-taking this time and betters (primarily hedgies) will expect this stock to do better next week. If the trial news are delayed until now, Janssen may have some announcement to make next week being the last week in July (or the end of mid 2015!!).
Southern, thanks for your honesty. You do have right reasons to doubt. But, now, you see glass half empty, wheras I see it half full. Meaning, you harbor pessimism and I harbor optimism.